{"id":351025,"date":"2025-08-25T20:20:54","date_gmt":"2025-08-25T20:20:54","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-celldex-therapeutics\/"},"modified":"2025-08-25T20:20:54","modified_gmt":"2025-08-25T20:20:54","slug":"how-to-buy-celldex-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-351025","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Celldex Therapeutics, Inc. (CLDX) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu CLDX","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Celldex Therapeutics, Inc. (CLDX) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu CLDX"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Celldex Therapeutics (CLDX) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u00e1nh gi\u00e1 r\u1ee7i ro v\u00e0 h\u01b0\u1edbng d\u1eabn mua t\u1eebng b\u01b0\u1edbc cho c\u00e1c c\u01a1 h\u1ed9i n\u0103m 2025.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Celldex Therapeutics (CLDX) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u00e1nh gi\u00e1 r\u1ee7i ro v\u00e0 h\u01b0\u1edbng d\u1eabn mua t\u1eebng b\u01b0\u1edbc cho c\u00e1c c\u01a1 h\u1ed9i n\u0103m 2025."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o \u0111\u1ed5i m\u1edbi c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn? Celldex Therapeutics \u0111\u1ea1i di\u1ec7n cho bi\u00ean gi\u1edbi \u0111\u1ea7y h\u1ee9ng kh\u1edfi c\u1ee7a c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb mi\u1ec5n d\u1ecbch h\u1ecdc. V\u1edbi li\u1ec7u ph\u00e1p barzolvolimab c\u00e1ch m\u1ea1ng c\u1ee7a h\u1ecd \u0111ang cho th\u1ea5y tri\u1ec3n v\u1ecdng \u0111\u1ed1i v\u1edbi c\u00e1c b\u1ec7nh vi\u00eam m\u00e3n t\u00ednh, c\u00f4ng ty n\u00e0y c\u00f3 th\u1ec3 l\u00e0 c\u00e1nh c\u1eeda d\u1eabn b\u1ea1n \u0111\u1ebfn t\u01b0\u01a1ng lai c\u1ee7a y h\u1ecdc\u2014v\u00e0 c\u00f3 th\u1ec3 l\u00e0 l\u1ee3i nhu\u1eadn \u0111\u00e1ng k\u1ec3.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o \u0111\u1ed5i m\u1edbi c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn? Celldex Therapeutics \u0111\u1ea1i di\u1ec7n cho bi\u00ean gi\u1edbi \u0111\u1ea7y h\u1ee9ng kh\u1edfi c\u1ee7a c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb mi\u1ec5n d\u1ecbch h\u1ecdc. V\u1edbi li\u1ec7u ph\u00e1p barzolvolimab c\u00e1ch m\u1ea1ng c\u1ee7a h\u1ecd \u0111ang cho th\u1ea5y tri\u1ec3n v\u1ecdng \u0111\u1ed1i v\u1edbi c\u00e1c b\u1ec7nh vi\u00eam m\u00e3n t\u00ednh, c\u00f4ng ty n\u00e0y c\u00f3 th\u1ec3 l\u00e0 c\u00e1nh c\u1eeda d\u1eabn b\u1ea1n \u0111\u1ebfn t\u01b0\u01a1ng lai c\u1ee7a y h\u1ecdc\u2014v\u00e0 c\u00f3 th\u1ec3 l\u00e0 l\u1ee3i nhu\u1eadn \u0111\u00e1ng k\u1ec3."},"body_html":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i v\u00e0 Ph\u00e2n T\u00edch Gi\u00e1<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Celldex Therapeutics (CLDX) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>22,46 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. M\u1ee9c gi\u00e1 n\u00e0y \u0111\u1ea1i di\u1ec7n cho m\u1ed9t \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn khi xem x\u00e9t h\u00e0nh tr\u00ecnh bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh c\u1ee7a c\u1ed5 phi\u1ebfu trong s\u00e1u th\u00e1ng qua.<\/p> <p><strong>C\u1ea3nh B\u00e1o Ng\u00e0y Quan Tr\u1ecdng<\/strong>: H\u00e3y \u0111\u00e1nh d\u1ea5u <strong>ng\u00e0y 5 th\u00e1ng 11 n\u0103m 2025<\/strong> v\u00e0o l\u1ecbch c\u1ee7a b\u1ea1n! \u0110\u00e2y l\u00e0 th\u1eddi \u0111i\u1ec3m Celldex c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp ti\u1ebfp theo. C\u00e1c m\u1eabu l\u1ecbch s\u1eed cho th\u1ea5y nh\u1eefng s\u1ef1 ki\u1ec7n n\u00e0y c\u00f3 th\u1ec3 k\u00edch ho\u1ea1t bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p> <h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng Thu Nh\u1eadp: L\u1ecbch S\u1eed D\u1ea1y Ch\u00fang Ta \u0110i\u1ec1u G\u00ec<\/h3> <p>Nh\u00ecn v\u00e0o ph\u1ea3n \u1ee9ng thu nh\u1eadp g\u1ea7n \u0111\u00e2y cung c\u1ea5p nh\u1eefng b\u00e0i h\u1ecdc qu\u00fd gi\u00e1 cho vi\u1ec7c \u0111\u1ecbnh th\u1eddi \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n:<\/p> <ul> <li><strong>B\u00e1o c\u00e1o Thu nh\u1eadp Qu\u00fd 2 ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025<\/strong>: Doanh thu kh\u00f4ng \u0111\u1ea1t \u01b0\u1edbc t\u00ednh trong khi EPS v\u01b0\u1ee3t nh\u1eb9 k\u1ef3 v\u1ecdng. C\u1ed5 phi\u1ebfu th\u1ec3 hi\u1ec7n s\u1ef1 b\u1ec1n b\u1ec9 m\u1eb7c d\u00f9 k\u1ebft qu\u1ea3 h\u1ed7n h\u1ee3p, ph\u1ea3n \u00e1nh ni\u1ec1m tin c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o danh m\u1ee5c d\u00e0i h\u1ea1n (<a href=\"https:\/\/www.stocktitan.net\/news\/CLDX\/celldex-reports-second-quarter-2025-financial-results-and-provides-l057wsu85430.html\">K\u1ebft qu\u1ea3 Qu\u00fd 2 n\u0103m 2025<\/a>)<\/li> <li><strong>M\u1eabu H\u00ecnh Tr\u01b0\u1edbc \u0110\u00f3<\/strong>: C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u01b0\u1eddng tr\u1ea3i qua bi\u1ebfn \u0111\u1ed9ng quanh k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 c\u1eadp nh\u1eadt FDA. M\u1ee9c gi\u1ea3m 8,3% g\u1ea7n \u0111\u00e2y sau k\u1ebft qu\u1ea3 giai \u0111o\u1ea1n 2 v\u1ec1 vi\u00eam th\u1ef1c qu\u1ea3n eosinophilic cho th\u1ea5y s\u1ef1 nh\u1ea1y c\u1ea3m n\u00e0y (<a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-cldx\/celldex-therapeutics\/news\/celldex-therapeutics-cldx-is-down-83-after-barzolvolimab-mis\">K\u1ebft qu\u1ea3 L\u00e2m s\u00e0ng G\u1ea7n \u0111\u00e2y<\/a>)<\/li> <\/ul> <p>B\u00e0i h\u1ecdc ch\u00ednh? B\u00e1o c\u00e1o thu nh\u1eadp t\u1ea1o ra c\u1ea3 r\u1ee7i ro v\u00e0 c\u01a1 h\u1ed9i\u2014ho\u00e0n h\u1ea3o cho c\u00e1c \u0111i\u1ec3m v\u00e0o chi\u1ebfn l\u01b0\u1ee3c.<\/p> <h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u00e0u L\u01b0\u1ee3n C\u1ea3m X\u00fac C\u00f3 M\u1ee5c \u0110\u00edch<\/h3> <p>Celldex \u0111\u00e3 \u0111\u01b0a nh\u00e0 \u0111\u1ea7u t\u01b0 tr\u1ea3i qua m\u1ed9t chuy\u1ebfn \u0111i kh\u00e1 th\u00fa v\u1ecb k\u1ec3 t\u1eeb th\u00e1ng 2 n\u0103m 2025:<\/p> <table> <thead> <tr><th>Th\u00e1ng<\/th><th>Kho\u1ea3ng Gi\u00e1<\/th><th>Hi\u1ec7u Su\u1ea5t<\/th><th>Y\u1ebfu T\u1ed1 Ch\u00ednh<\/th><\/tr> <\/thead> <tbody> <tr><td>Th\u00e1ng 3 n\u0103m 2025<\/td><td>17,63 USD - 22,33 USD<\/td><td>-11,76%<\/td><td>B\u1ea5t \u1ed5n th\u1ecb tr\u01b0\u1eddng<\/td><\/tr> <tr><td>Th\u00e1ng 4 n\u0103m 2025<\/td><td>14,40 USD - 21,58 USD<\/td><td>+14,77%<\/td><td>T\u00ecm \u0111\u01b0\u1ee3c h\u1ed7 tr\u1ee3 t\u1ea1i 14,40 USD<\/td><\/tr> <tr><td>Th\u00e1ng 5 n\u0103m 2025<\/td><td>17,85 USD - 21,23 USD<\/td><td>-5,04%<\/td><td>Giai \u0111o\u1ea1n c\u1ee7ng c\u1ed1<\/td><\/tr> <tr><td>Th\u00e1ng 6 n\u0103m 2025<\/td><td>19,25 USD - 24,03 USD<\/td><td>+2,88%<\/td><td>D\u1ea5u hi\u1ec7u ph\u1ee5c h\u1ed3i s\u1edbm<\/td><\/tr> <tr><td>Th\u00e1ng 7 n\u0103m 2025<\/td><td>20,01 USD - 24,05 USD<\/td><td>+13,34%<\/td><td>X\u00e2y d\u1ef1ng \u0111\u1ed9ng l\u1ef1c m\u1ea1nh m\u1ebd<\/td><\/tr> <tr><td>Th\u00e1ng 8 n\u0103m 2025<\/td><td>20,71 USD - 25,54 USD<\/td><td>\u0110ang ti\u1ebfp di\u1ec5n<\/td><td>C\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/td><\/tr> <\/tbody> <\/table> <p>S\u1ef1 bi\u1ebfn \u0111\u1ed9ng n\u00e0y kh\u00f4ng ph\u1ea3i ng\u1eabu nhi\u00ean\u2014n\u00f3 ph\u1ea3n \u00e1nh b\u1ea3n ch\u1ea5t r\u1ee7i ro cao, ph\u1ea7n th\u01b0\u1edfng cao c\u1ee7a \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng. C\u1ed5 phi\u1ebfu \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 ph\u1ee5c h\u1ed3i \u0111\u00e1ng k\u1ec3 t\u1eeb m\u1ee9c th\u1ea5p th\u00e1ng 4 l\u00e0 14,40 USD, t\u0103ng kho\u1ea3ng 66% t\u1eeb \u0111\u00e1y \u0111\u00f3.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 mang l\u1ea1i:<\/p> <p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: M\u1ee9c 40-50 USD (D\u1eef li\u1ec7u l\u00e2m s\u00e0ng m\u1ea1nh c\u00f3 th\u1ec3 th\u00fac \u0111\u1ea9y l\u1ee3i nhu\u1eadn tr\u00ean 100%)<br> <strong>D\u1ef1 b\u00e1o 2026<\/strong>: 55-70 USD (Kh\u1ea3 n\u0103ng n\u1ed9p h\u1ed3 s\u01a1 FDA v\u00e0 h\u1ee3p t\u00e1c)<br> <strong>Tri\u1ec3n v\u1ecdng 2028<\/strong>: 80-120 USD (Giai \u0111o\u1ea1n th\u01b0\u01a1ng m\u1ea1i h\u00f3a n\u1ebfu \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t)<br> <strong>T\u1ea7m nh\u00ecn 2030<\/strong>: 150-200+ USD (V\u1ecb th\u1ebf th\u1ecb tr\u01b0\u1eddng v\u1eefng ch\u1eafc trong l\u0129nh v\u1ef1c mi\u1ec5n d\u1ecbch h\u1ecdc)<\/p> <p><strong>K\u1ebft lu\u1eadn<\/strong>: MUA M\u1ea0NH cho nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro. Gi\u00e1 hi\u1ec7n t\u1ea1i cung c\u1ea5p \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn tr\u01b0\u1edbc c\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u00e2m s\u00e0ng ti\u1ec1m n\u0103ng.<\/p> <h3>T\u1ea1i Sao Th\u1eddi \u0110i\u1ec3m N\u00e0y Quan Tr\u1ecdng<\/h3> <p>V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t 630,3 tri\u1ec7u USD c\u1ee7a c\u00f4ng ty cung c\u1ea5p ngu\u1ed3n l\u1ef1c \u0111\u1ebfn n\u0103m 2027, gi\u1ea3m thi\u1ec3u r\u1ee7i ro pha lo\u00e3ng ng\u1eafn h\u1ea1n (<a href=\"https:\/\/www.stocktitan.net\/news\/CLDX\/celldex-reports-second-quarter-2025-financial-results-and-provides-l057wsu85430.html\">S\u1ee9c M\u1ea1nh T\u00e0i Ch\u00ednh<\/a>). V\u1edbi nhi\u1ec1u th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 3 \u0111ang ti\u1ebfn h\u00e0nh, n\u0103m 2025-2026 c\u00f3 th\u1ec3 l\u00e0 nh\u1eefng n\u0103m chuy\u1ec3n \u0111\u1ed5i.<\/p> <h2>\u26a0\ufe0f \u0110\u00e1nh Gi\u00e1 R\u1ee7i Ro: \u0110i\u1ec1u H\u01b0\u1edbng Bi\u1ebfn \u0110\u1ed9ng C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc<\/h2> <h3>R\u1ee7i Ro Ti\u1ec1m \u1ea8n<\/h3> <ul> <li><strong>Th\u1ea5t B\u1ea1i Th\u1eed Nghi\u1ec7m L\u00e2m S\u00e0ng<\/strong>: 41% c\u00e1c th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 3 th\u1ea5t b\u1ea1i\u2014b\u1ea5t k\u1ef3 tr\u1edf ng\u1ea1i n\u00e0o c\u0169ng c\u00f3 th\u1ec3 l\u00e0m s\u1ee5t gi\u1ea3m c\u1ed5 phi\u1ebfu<\/li> <li><strong>R\u00e0o C\u1ea3n Ph\u00e1p L\u00fd<\/strong>: FDA t\u1eeb ch\u1ed1i ho\u1eb7c tr\u00ec ho\u00e3n c\u00f3 th\u1ec3 g\u00e2y gi\u1ea3m tr\u00ean 50% ch\u1ec9 sau m\u1ed9t \u0111\u00eam<\/li> <li><strong>Ti\u00eau Hao Ti\u1ec1n M\u1eb7t<\/strong>: L\u1ed7 56,6 tri\u1ec7u USD m\u1ed7i qu\u00fd \u0111\u00f2i h\u1ecfi qu\u1ea3n l\u00fd v\u1ed1n c\u1ea9n th\u1eadn<\/li> <li><strong>C\u1ea1nh Tranh<\/strong>: C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n ph\u00e1t tri\u1ec3n li\u1ec7u ph\u00e1p t\u01b0\u01a1ng t\u1ef1<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3> <ul> <li><strong>Th\u00e0nh C\u00f4ng Barzolvolimab<\/strong>: T\u1ef7 l\u1ec7 \u0111\u00e1p \u1ee9ng ho\u00e0n to\u00e0n 41% trong th\u1eed nghi\u1ec7m vi\u00eam m\u00e0y \u0111ay m\u00e3n t\u00ednh l\u00e0 xu\u1ea5t s\u1eafc (<a href=\"https:\/\/www.stocktitan.net\/news\/CLDX\/celldex-reports-second-quarter-2025-financial-results-and-provides-l057wsu85430.html\">K\u1ebft Qu\u1ea3 Th\u1eed Nghi\u1ec7m<\/a>)<\/li> <li><strong>Ti\u1ec1m N\u0103ng Th\u1ecb Tr\u01b0\u1eddng<\/strong>: C\u00e1c b\u1ec7nh vi\u00eam m\u00e3n t\u00ednh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n c\u1ea7u<\/li> <li><strong>V\u1ecb Th\u1ebf Ti\u1ec1n M\u1eb7t M\u1ea1nh<\/strong>: Kh\u00f4ng c\u00f3 lo ng\u1ea1i v\u1ec1 t\u00e0i ch\u00ednh ngay l\u1eadp t\u1ee9c<\/li> <li><strong>H\u1ed7 Tr\u1ee3 T\u1eeb Nh\u00e0 Ph\u00e2n T\u00edch<\/strong>: 8 nh\u00e0 ph\u00e2n t\u00edch khuy\u1ebfn ngh\u1ecb \"Mua M\u1ea1nh\" v\u1edbi m\u1ee5c ti\u00eau trung b\u00ecnh 46,13 USD<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Chi\u1ebfn L\u01b0\u1ee3c Th\u00f4ng Minh Cho Nh\u00e0 Giao D\u1ecbch M\u1edbi<\/h2> <p><strong>K\u1ebf Ho\u1ea1ch H\u00e0nh \u0110\u1ed9ng H\u00f4m Nay:<\/strong><\/p> <ol> <li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 ch\u1ec9 2-5% danh m\u1ee5c cho c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li> <li><strong>Trung B\u00ecnh Gi\u00e1 \u0110\u00f4 La<\/strong>: Mua theo t\u1eebng ph\u1ea7n thay v\u00ec m\u1ed9t l\u1ea7n<\/li> <li><strong>\u0110\u1eb7t L\u1ec7nh C\u1eaft L\u1ed7<\/strong>: B\u1ea3o v\u1ec7 kh\u1ecfi s\u1ee5t gi\u1ea3m th\u1ea3m kh\u1ed1c (g\u1ee3i \u00fd 15-20% d\u01b0\u1edbi gi\u00e1 v\u00e0o)<\/li> <li><strong>Gi\u00e1m S\u00e1t C\u00e1c Ch\u1ea5t X\u00fac T\u00e1c<\/strong>: Theo d\u00f5i b\u00e1o c\u00e1o thu nh\u1eadp th\u00e1ng 11 v\u00e0 c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng<\/li> <\/ol> <p><strong>Ki\u1ec3m Tra Th\u1ef1c T\u1ebf H\u00e0i H\u01b0\u1edbc<\/strong>: \"Giao d\u1ecbch CLDX gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc xu\u1ea5t s\u1eafc\u2014ti\u1ec1m n\u0103ng tuy\u1ec7t v\u1eddi nh\u01b0ng d\u1ec5 b\u00f9ng n\u1ed5 b\u1ea5t ng\u1edd. H\u00e3y lu\u00f4n \u0111eo k\u00ednh b\u1ea3o h\u1ed9!\"<\/p> <h2>\u2705 H\u01b0\u1edbng D\u1eabn T\u1eebng B\u01b0\u1edbc: C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Celldex Therapeutics (CLDX)<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn N\u1ec1n T\u1ea3ng C\u1ee7a B\u1ea1n<\/td><td>Ch\u1ecdn nh\u00e0 m\u00f4i gi\u1edbi c\u00f3 truy c\u1eadp NASDAQ v\u00e0 ph\u00ed h\u1ee3p l\u00fd<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n Th\u00e0nh X\u00e1c Minh<\/td><td>Cung c\u1ea5p gi\u1ea5y t\u1edd t\u00f9y th\u00e2n\u2014th\u01b0\u1eddng m\u1ea5t v\u00e0i ph\u00fat<\/td><\/tr> <tr><td>3<\/td><td>N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td><\/tr> <tr><td>4<\/td><td>T\u00ecm ki\u1ebfm \"CLDX\"<\/td><td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ph\u1ea3i t\u00ean c\u00f4ng ty<\/td><\/tr> <tr><td>5<\/td><td>\u0110\u1eb7t L\u1ec7nh Gi\u1edbi H\u1ea1n<\/td><td>Ch\u1ec9 \u0111\u1ecbnh gi\u00e1 t\u1ed1i \u0111a b\u1ea1n s\u1ebd tr\u1ea3 (g\u1ee3i \u00fd 23-24 USD)<\/td><\/tr> <tr><td>6<\/td><td>Xem L\u1ea1i Chi Ti\u1ebft L\u1ec7nh<\/td><td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng v\u00e0 lo\u1ea1i l\u1ec7nh<\/td><\/tr> <tr><td>7<\/td><td>Th\u1ef1c Hi\u1ec7n Mua<\/td><td>X\u00e1c nh\u1eadn l\u1ec7nh mua c\u1ee7a b\u1ea1n<\/td><\/tr> <tr><td>8<\/td><td>\u0110\u1eb7t C\u1ea3nh B\u00e1o Gi\u00e1<\/td><td>Nh\u1eadn th\u00f4ng b\u00e1o t\u1ea1i c\u00e1c m\u1ee9c gi\u00e1 quan tr\u1ecdng<\/td><\/tr> <tr><td>9<\/td><td>Gi\u00e1m S\u00e1t V\u1ecb Th\u1ebf<\/td><td>Theo d\u00f5i hi\u1ec7u su\u1ea5t th\u01b0\u1eddng xuy\u00ean<\/td><\/tr> <tr><td>10<\/td><td>L\u1eadp K\u1ebf Ho\u1ea1ch Tho\u00e1t<\/td><td>Quy\u1ebft \u0111\u1ecbnh m\u1ee9c ch\u1ed1t l\u1eddi v\u00e0 c\u1eaft l\u1ed7 tr\u01b0\u1edbc<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Thu H\u00fat Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf ph\u00f9 h\u1ee3p ho\u00e0n h\u1ea3o v\u1edbi \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc:<\/p> <p><strong>Ti\u1ec1n G\u1eedi T\u1ed1i Thi\u1ec3u Linh Ho\u1ea1t<\/strong>: Ch\u1ec9 c\u1ea7n 5 USD \u0111\u1ec3 b\u1eaft \u0111\u1ea7u, b\u1ea1n c\u00f3 th\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro t\u1ed1i thi\u1ec3u\u2014\u0111i\u1ec1u quan tr\u1ecdng khi giao d\u1ecbch c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng nh\u01b0 CLDX.<\/p> <p><strong>X\u00e1c Minh Nhanh Ch\u00f3ng<\/strong>: Quy tr\u00ecnh KYC 1 ph\u00fat gi\u00fap b\u1ea1n t\u1eadn d\u1ee5ng c\u01a1 h\u1ed9i th\u1ecb tr\u01b0\u1eddng ngay khi c\u00f3.<\/p> <p><strong>Nhi\u1ec1u Ph\u01b0\u01a1ng Th\u1ee9c R\u00fat Ti\u1ec1n<\/strong>: H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c \u0111\u1ea3m b\u1ea3o b\u1ea1n c\u00f3 th\u1ec3 truy c\u1eadp l\u1ee3i nhu\u1eadn thu\u1eadn ti\u1ec7n, d\u00f9 b\u1ea1n th\u00edch ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed hay ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng.<\/p> <p>S\u1ef1 k\u1ebft h\u1ee3p gi\u1eefa kh\u1ea3 n\u0103ng ti\u1ebfp c\u1eadn v\u00e0 linh ho\u1ea1t n\u00e0y khi\u1ebfn Pocket Option \u0111\u1eb7c bi\u1ec7t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n kh\u00e1m ph\u00e1 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u1ec1m n\u0103ng cao m\u00e0 kh\u00f4ng c\u1ea7n cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn ban \u0111\u1ea7u.<\/p> <h2>\ud83c\udf0d Celldex Therapeutics N\u0103m 2025: Nh\u00e0 \u0110\u1ed5i M\u1edbi Mi\u1ec5n D\u1ecbch H\u1ecdc<\/h2> <p>Celldex \u0111\u00e3 chuy\u1ec3n m\u00ecnh t\u1eeb c\u00f4ng ty t\u1eadp trung v\u00e0o ung th\u01b0 sang chuy\u00ean gia thu\u1ea7n t\u00fay v\u1ec1 mi\u1ec5n d\u1ecbch h\u1ecdc. Chi\u1ebfn l\u01b0\u1ee3c chuy\u1ec3n h\u01b0\u1edbng sang c\u00e1c b\u1ec7nh do t\u1ebf b\u00e0o mast trung gian th\u1ec3 hi\u1ec7n c\u00e1ch ti\u1ebfp c\u1eadn t\u1eadp trung \u0111\u1ec3 gi\u1ea3i quy\u1ebft c\u00e1c b\u1ec7nh vi\u00eam m\u00e3n t\u00ednh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n th\u1ebf gi\u1edbi.<\/p> <p>Thu\u1ed1c ch\u1ee7 l\u1ef1c c\u1ee7a c\u00f4ng ty, barzolvolimab, nh\u1eafm v\u00e0o th\u1ee5 th\u1ec3 KIT\u2014m\u1ed9t ph\u01b0\u01a1ng ph\u00e1p m\u1edbi c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh nh\u01b0 vi\u00eam m\u00e0y \u0111ay m\u00e3n t\u00ednh, prurigo nodularis v\u00e0 vi\u00eam th\u1ef1c qu\u1ea3n eosinophilic. V\u1edbi 186 nh\u00e2n vi\u00ean bao g\u1ed3m 87 nh\u00e0 khoa h\u1ecdc nghi\u00ean c\u1ee9u, h\u1ecd duy tr\u00ec n\u0103ng l\u1ef1c ph\u00e1t tri\u1ec3n n\u1ed9i b\u1ed9 m\u1ea1nh m\u1ebd (<a href=\"https:\/\/stockanalysis.com\/stocks\/cldx\/company\/\">H\u1ed3 S\u01a1 C\u00f4ng Ty<\/a>).<\/p> <p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb Cho N\u0103m 2025<\/strong>: Nh\u00f3m nghi\u00ean c\u1ee9u c\u1ee7a Celldex ph\u00e1t hi\u1ec7n r\u1eb1ng t\u1ebf b\u00e0o mast\u2014t\u1eebng \u0111\u01b0\u1ee3c coi l\u00e0 ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng \u0111\u01a1n gi\u1ea3n\u2014th\u1ef1c s\u1ef1 \u0111\u00f3ng vai tr\u00f2 trung t\u00e2m trong h\u01a1n 50 b\u1ec7nh vi\u00eam kh\u00e1c nhau, m\u1edf ra m\u1ed9t th\u1ecb tr\u01b0\u1eddng ti\u1ec1m n\u0103ng kh\u1ed5ng l\u1ed3 c\u00f3 th\u1ec3 v\u01b0\u1ee3t qu\u00e1 20 t\u1ef7 USD m\u1ed7i n\u0103m.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i v\u00e0 Ph\u00e2n T\u00edch Gi\u00e1<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Celldex Therapeutics (CLDX) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>22,46 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. M\u1ee9c gi\u00e1 n\u00e0y \u0111\u1ea1i di\u1ec7n cho m\u1ed9t \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn khi xem x\u00e9t h\u00e0nh tr\u00ecnh bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh c\u1ee7a c\u1ed5 phi\u1ebfu trong s\u00e1u th\u00e1ng qua.<\/p>\n<p><strong>C\u1ea3nh B\u00e1o Ng\u00e0y Quan Tr\u1ecdng<\/strong>: H\u00e3y \u0111\u00e1nh d\u1ea5u <strong>ng\u00e0y 5 th\u00e1ng 11 n\u0103m 2025<\/strong> v\u00e0o l\u1ecbch c\u1ee7a b\u1ea1n! \u0110\u00e2y l\u00e0 th\u1eddi \u0111i\u1ec3m Celldex c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp ti\u1ebfp theo. C\u00e1c m\u1eabu l\u1ecbch s\u1eed cho th\u1ea5y nh\u1eefng s\u1ef1 ki\u1ec7n n\u00e0y c\u00f3 th\u1ec3 k\u00edch ho\u1ea1t bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p>\n<h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng Thu Nh\u1eadp: L\u1ecbch S\u1eed D\u1ea1y Ch\u00fang Ta \u0110i\u1ec1u G\u00ec<\/h3>\n<p>Nh\u00ecn v\u00e0o ph\u1ea3n \u1ee9ng thu nh\u1eadp g\u1ea7n \u0111\u00e2y cung c\u1ea5p nh\u1eefng b\u00e0i h\u1ecdc qu\u00fd gi\u00e1 cho vi\u1ec7c \u0111\u1ecbnh th\u1eddi \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n:<\/p>\n<ul>\n<li><strong>B\u00e1o c\u00e1o Thu nh\u1eadp Qu\u00fd 2 ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025<\/strong>: Doanh thu kh\u00f4ng \u0111\u1ea1t \u01b0\u1edbc t\u00ednh trong khi EPS v\u01b0\u1ee3t nh\u1eb9 k\u1ef3 v\u1ecdng. C\u1ed5 phi\u1ebfu th\u1ec3 hi\u1ec7n s\u1ef1 b\u1ec1n b\u1ec9 m\u1eb7c d\u00f9 k\u1ebft qu\u1ea3 h\u1ed7n h\u1ee3p, ph\u1ea3n \u00e1nh ni\u1ec1m tin c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o danh m\u1ee5c d\u00e0i h\u1ea1n (<a href=\"https:\/\/www.stocktitan.net\/news\/CLDX\/celldex-reports-second-quarter-2025-financial-results-and-provides-l057wsu85430.html\">K\u1ebft qu\u1ea3 Qu\u00fd 2 n\u0103m 2025<\/a>)<\/li>\n<li><strong>M\u1eabu H\u00ecnh Tr\u01b0\u1edbc \u0110\u00f3<\/strong>: C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u01b0\u1eddng tr\u1ea3i qua bi\u1ebfn \u0111\u1ed9ng quanh k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 c\u1eadp nh\u1eadt FDA. M\u1ee9c gi\u1ea3m 8,3% g\u1ea7n \u0111\u00e2y sau k\u1ebft qu\u1ea3 giai \u0111o\u1ea1n 2 v\u1ec1 vi\u00eam th\u1ef1c qu\u1ea3n eosinophilic cho th\u1ea5y s\u1ef1 nh\u1ea1y c\u1ea3m n\u00e0y (<a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-cldx\/celldex-therapeutics\/news\/celldex-therapeutics-cldx-is-down-83-after-barzolvolimab-mis\">K\u1ebft qu\u1ea3 L\u00e2m s\u00e0ng G\u1ea7n \u0111\u00e2y<\/a>)<\/li>\n<\/ul>\n<p>B\u00e0i h\u1ecdc ch\u00ednh? B\u00e1o c\u00e1o thu nh\u1eadp t\u1ea1o ra c\u1ea3 r\u1ee7i ro v\u00e0 c\u01a1 h\u1ed9i\u2014ho\u00e0n h\u1ea3o cho c\u00e1c \u0111i\u1ec3m v\u00e0o chi\u1ebfn l\u01b0\u1ee3c.<\/p>\n<h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u00e0u L\u01b0\u1ee3n C\u1ea3m X\u00fac C\u00f3 M\u1ee5c \u0110\u00edch<\/h3>\n<p>Celldex \u0111\u00e3 \u0111\u01b0a nh\u00e0 \u0111\u1ea7u t\u01b0 tr\u1ea3i qua m\u1ed9t chuy\u1ebfn \u0111i kh\u00e1 th\u00fa v\u1ecb k\u1ec3 t\u1eeb th\u00e1ng 2 n\u0103m 2025:<\/p>\n<table>\n<thead>\n<tr>\n<th>Th\u00e1ng<\/th>\n<th>Kho\u1ea3ng Gi\u00e1<\/th>\n<th>Hi\u1ec7u Su\u1ea5t<\/th>\n<th>Y\u1ebfu T\u1ed1 Ch\u00ednh<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Th\u00e1ng 3 n\u0103m 2025<\/td>\n<td>17,63 USD &#8211; 22,33 USD<\/td>\n<td>-11,76%<\/td>\n<td>B\u1ea5t \u1ed5n th\u1ecb tr\u01b0\u1eddng<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 4 n\u0103m 2025<\/td>\n<td>14,40 USD &#8211; 21,58 USD<\/td>\n<td>+14,77%<\/td>\n<td>T\u00ecm \u0111\u01b0\u1ee3c h\u1ed7 tr\u1ee3 t\u1ea1i 14,40 USD<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 5 n\u0103m 2025<\/td>\n<td>17,85 USD &#8211; 21,23 USD<\/td>\n<td>-5,04%<\/td>\n<td>Giai \u0111o\u1ea1n c\u1ee7ng c\u1ed1<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 6 n\u0103m 2025<\/td>\n<td>19,25 USD &#8211; 24,03 USD<\/td>\n<td>+2,88%<\/td>\n<td>D\u1ea5u hi\u1ec7u ph\u1ee5c h\u1ed3i s\u1edbm<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 7 n\u0103m 2025<\/td>\n<td>20,01 USD &#8211; 24,05 USD<\/td>\n<td>+13,34%<\/td>\n<td>X\u00e2y d\u1ef1ng \u0111\u1ed9ng l\u1ef1c m\u1ea1nh m\u1ebd<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 8 n\u0103m 2025<\/td>\n<td>20,71 USD &#8211; 25,54 USD<\/td>\n<td>\u0110ang ti\u1ebfp di\u1ec5n<\/td>\n<td>C\u1eadp nh\u1eadt th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>S\u1ef1 bi\u1ebfn \u0111\u1ed9ng n\u00e0y kh\u00f4ng ph\u1ea3i ng\u1eabu nhi\u00ean\u2014n\u00f3 ph\u1ea3n \u00e1nh b\u1ea3n ch\u1ea5t r\u1ee7i ro cao, ph\u1ea7n th\u01b0\u1edfng cao c\u1ee7a \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng. C\u1ed5 phi\u1ebfu \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 ph\u1ee5c h\u1ed3i \u0111\u00e1ng k\u1ec3 t\u1eeb m\u1ee9c th\u1ea5p th\u00e1ng 4 l\u00e0 14,40 USD, t\u0103ng kho\u1ea3ng 66% t\u1eeb \u0111\u00e1y \u0111\u00f3.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 mang l\u1ea1i:<\/p>\n<p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: M\u1ee9c 40-50 USD (D\u1eef li\u1ec7u l\u00e2m s\u00e0ng m\u1ea1nh c\u00f3 th\u1ec3 th\u00fac \u0111\u1ea9y l\u1ee3i nhu\u1eadn tr\u00ean 100%)<br \/> <strong>D\u1ef1 b\u00e1o 2026<\/strong>: 55-70 USD (Kh\u1ea3 n\u0103ng n\u1ed9p h\u1ed3 s\u01a1 FDA v\u00e0 h\u1ee3p t\u00e1c)<br \/> <strong>Tri\u1ec3n v\u1ecdng 2028<\/strong>: 80-120 USD (Giai \u0111o\u1ea1n th\u01b0\u01a1ng m\u1ea1i h\u00f3a n\u1ebfu \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t)<br \/> <strong>T\u1ea7m nh\u00ecn 2030<\/strong>: 150-200+ USD (V\u1ecb th\u1ebf th\u1ecb tr\u01b0\u1eddng v\u1eefng ch\u1eafc trong l\u0129nh v\u1ef1c mi\u1ec5n d\u1ecbch h\u1ecdc)<\/p>\n<p><strong>K\u1ebft lu\u1eadn<\/strong>: MUA M\u1ea0NH cho nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro. Gi\u00e1 hi\u1ec7n t\u1ea1i cung c\u1ea5p \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn tr\u01b0\u1edbc c\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u00e2m s\u00e0ng ti\u1ec1m n\u0103ng.<\/p>\n<h3>T\u1ea1i Sao Th\u1eddi \u0110i\u1ec3m N\u00e0y Quan Tr\u1ecdng<\/h3>\n<p>V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t 630,3 tri\u1ec7u USD c\u1ee7a c\u00f4ng ty cung c\u1ea5p ngu\u1ed3n l\u1ef1c \u0111\u1ebfn n\u0103m 2027, gi\u1ea3m thi\u1ec3u r\u1ee7i ro pha lo\u00e3ng ng\u1eafn h\u1ea1n (<a href=\"https:\/\/www.stocktitan.net\/news\/CLDX\/celldex-reports-second-quarter-2025-financial-results-and-provides-l057wsu85430.html\">S\u1ee9c M\u1ea1nh T\u00e0i Ch\u00ednh<\/a>). V\u1edbi nhi\u1ec1u th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 3 \u0111ang ti\u1ebfn h\u00e0nh, n\u0103m 2025-2026 c\u00f3 th\u1ec3 l\u00e0 nh\u1eefng n\u0103m chuy\u1ec3n \u0111\u1ed5i.<\/p>\n<h2>\u26a0\ufe0f \u0110\u00e1nh Gi\u00e1 R\u1ee7i Ro: \u0110i\u1ec1u H\u01b0\u1edbng Bi\u1ebfn \u0110\u1ed9ng C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc<\/h2>\n<h3>R\u1ee7i Ro Ti\u1ec1m \u1ea8n<\/h3>\n<ul>\n<li><strong>Th\u1ea5t B\u1ea1i Th\u1eed Nghi\u1ec7m L\u00e2m S\u00e0ng<\/strong>: 41% c\u00e1c th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 3 th\u1ea5t b\u1ea1i\u2014b\u1ea5t k\u1ef3 tr\u1edf ng\u1ea1i n\u00e0o c\u0169ng c\u00f3 th\u1ec3 l\u00e0m s\u1ee5t gi\u1ea3m c\u1ed5 phi\u1ebfu<\/li>\n<li><strong>R\u00e0o C\u1ea3n Ph\u00e1p L\u00fd<\/strong>: FDA t\u1eeb ch\u1ed1i ho\u1eb7c tr\u00ec ho\u00e3n c\u00f3 th\u1ec3 g\u00e2y gi\u1ea3m tr\u00ean 50% ch\u1ec9 sau m\u1ed9t \u0111\u00eam<\/li>\n<li><strong>Ti\u00eau Hao Ti\u1ec1n M\u1eb7t<\/strong>: L\u1ed7 56,6 tri\u1ec7u USD m\u1ed7i qu\u00fd \u0111\u00f2i h\u1ecfi qu\u1ea3n l\u00fd v\u1ed1n c\u1ea9n th\u1eadn<\/li>\n<li><strong>C\u1ea1nh Tranh<\/strong>: C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n ph\u00e1t tri\u1ec3n li\u1ec7u ph\u00e1p t\u01b0\u01a1ng t\u1ef1<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3>\n<ul>\n<li><strong>Th\u00e0nh C\u00f4ng Barzolvolimab<\/strong>: T\u1ef7 l\u1ec7 \u0111\u00e1p \u1ee9ng ho\u00e0n to\u00e0n 41% trong th\u1eed nghi\u1ec7m vi\u00eam m\u00e0y \u0111ay m\u00e3n t\u00ednh l\u00e0 xu\u1ea5t s\u1eafc (<a href=\"https:\/\/www.stocktitan.net\/news\/CLDX\/celldex-reports-second-quarter-2025-financial-results-and-provides-l057wsu85430.html\">K\u1ebft Qu\u1ea3 Th\u1eed Nghi\u1ec7m<\/a>)<\/li>\n<li><strong>Ti\u1ec1m N\u0103ng Th\u1ecb Tr\u01b0\u1eddng<\/strong>: C\u00e1c b\u1ec7nh vi\u00eam m\u00e3n t\u00ednh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n c\u1ea7u<\/li>\n<li><strong>V\u1ecb Th\u1ebf Ti\u1ec1n M\u1eb7t M\u1ea1nh<\/strong>: Kh\u00f4ng c\u00f3 lo ng\u1ea1i v\u1ec1 t\u00e0i ch\u00ednh ngay l\u1eadp t\u1ee9c<\/li>\n<li><strong>H\u1ed7 Tr\u1ee3 T\u1eeb Nh\u00e0 Ph\u00e2n T\u00edch<\/strong>: 8 nh\u00e0 ph\u00e2n t\u00edch khuy\u1ebfn ngh\u1ecb &#8220;Mua M\u1ea1nh&#8221; v\u1edbi m\u1ee5c ti\u00eau trung b\u00ecnh 46,13 USD<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Chi\u1ebfn L\u01b0\u1ee3c Th\u00f4ng Minh Cho Nh\u00e0 Giao D\u1ecbch M\u1edbi<\/h2>\n<p><strong>K\u1ebf Ho\u1ea1ch H\u00e0nh \u0110\u1ed9ng H\u00f4m Nay:<\/strong><\/p>\n<ol>\n<li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 ch\u1ec9 2-5% danh m\u1ee5c cho c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li>\n<li><strong>Trung B\u00ecnh Gi\u00e1 \u0110\u00f4 La<\/strong>: Mua theo t\u1eebng ph\u1ea7n thay v\u00ec m\u1ed9t l\u1ea7n<\/li>\n<li><strong>\u0110\u1eb7t L\u1ec7nh C\u1eaft L\u1ed7<\/strong>: B\u1ea3o v\u1ec7 kh\u1ecfi s\u1ee5t gi\u1ea3m th\u1ea3m kh\u1ed1c (g\u1ee3i \u00fd 15-20% d\u01b0\u1edbi gi\u00e1 v\u00e0o)<\/li>\n<li><strong>Gi\u00e1m S\u00e1t C\u00e1c Ch\u1ea5t X\u00fac T\u00e1c<\/strong>: Theo d\u00f5i b\u00e1o c\u00e1o thu nh\u1eadp th\u00e1ng 11 v\u00e0 c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng<\/li>\n<\/ol>\n<p><strong>Ki\u1ec3m Tra Th\u1ef1c T\u1ebf H\u00e0i H\u01b0\u1edbc<\/strong>: &#8220;Giao d\u1ecbch CLDX gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc xu\u1ea5t s\u1eafc\u2014ti\u1ec1m n\u0103ng tuy\u1ec7t v\u1eddi nh\u01b0ng d\u1ec5 b\u00f9ng n\u1ed5 b\u1ea5t ng\u1edd. H\u00e3y lu\u00f4n \u0111eo k\u00ednh b\u1ea3o h\u1ed9!&#8221;<\/p>\n<h2>\u2705 H\u01b0\u1edbng D\u1eabn T\u1eebng B\u01b0\u1edbc: C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Celldex Therapeutics (CLDX)<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn N\u1ec1n T\u1ea3ng C\u1ee7a B\u1ea1n<\/td>\n<td>Ch\u1ecdn nh\u00e0 m\u00f4i gi\u1edbi c\u00f3 truy c\u1eadp NASDAQ v\u00e0 ph\u00ed h\u1ee3p l\u00fd<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n Th\u00e0nh X\u00e1c Minh<\/td>\n<td>Cung c\u1ea5p gi\u1ea5y t\u1edd t\u00f9y th\u00e2n\u2014th\u01b0\u1eddng m\u1ea5t v\u00e0i ph\u00fat<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;CLDX&#8221;<\/td>\n<td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ph\u1ea3i t\u00ean c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0110\u1eb7t L\u1ec7nh Gi\u1edbi H\u1ea1n<\/td>\n<td>Ch\u1ec9 \u0111\u1ecbnh gi\u00e1 t\u1ed1i \u0111a b\u1ea1n s\u1ebd tr\u1ea3 (g\u1ee3i \u00fd 23-24 USD)<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Xem L\u1ea1i Chi Ti\u1ebft L\u1ec7nh<\/td>\n<td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng v\u00e0 lo\u1ea1i l\u1ec7nh<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Th\u1ef1c Hi\u1ec7n Mua<\/td>\n<td>X\u00e1c nh\u1eadn l\u1ec7nh mua c\u1ee7a b\u1ea1n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>\u0110\u1eb7t C\u1ea3nh B\u00e1o Gi\u00e1<\/td>\n<td>Nh\u1eadn th\u00f4ng b\u00e1o t\u1ea1i c\u00e1c m\u1ee9c gi\u00e1 quan tr\u1ecdng<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Gi\u00e1m S\u00e1t V\u1ecb Th\u1ebf<\/td>\n<td>Theo d\u00f5i hi\u1ec7u su\u1ea5t th\u01b0\u1eddng xuy\u00ean<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>L\u1eadp K\u1ebf Ho\u1ea1ch Tho\u00e1t<\/td>\n<td>Quy\u1ebft \u0111\u1ecbnh m\u1ee9c ch\u1ed1t l\u1eddi v\u00e0 c\u1eaft l\u1ed7 tr\u01b0\u1edbc<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Thu H\u00fat Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf ph\u00f9 h\u1ee3p ho\u00e0n h\u1ea3o v\u1edbi \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc:<\/p>\n<p><strong>Ti\u1ec1n G\u1eedi T\u1ed1i Thi\u1ec3u Linh Ho\u1ea1t<\/strong>: Ch\u1ec9 c\u1ea7n 5 USD \u0111\u1ec3 b\u1eaft \u0111\u1ea7u, b\u1ea1n c\u00f3 th\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro t\u1ed1i thi\u1ec3u\u2014\u0111i\u1ec1u quan tr\u1ecdng khi giao d\u1ecbch c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng nh\u01b0 CLDX.<\/p>\n<p><strong>X\u00e1c Minh Nhanh Ch\u00f3ng<\/strong>: Quy tr\u00ecnh KYC 1 ph\u00fat gi\u00fap b\u1ea1n t\u1eadn d\u1ee5ng c\u01a1 h\u1ed9i th\u1ecb tr\u01b0\u1eddng ngay khi c\u00f3.<\/p>\n<p><strong>Nhi\u1ec1u Ph\u01b0\u01a1ng Th\u1ee9c R\u00fat Ti\u1ec1n<\/strong>: H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c \u0111\u1ea3m b\u1ea3o b\u1ea1n c\u00f3 th\u1ec3 truy c\u1eadp l\u1ee3i nhu\u1eadn thu\u1eadn ti\u1ec7n, d\u00f9 b\u1ea1n th\u00edch ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed hay ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng.<\/p>\n<p>S\u1ef1 k\u1ebft h\u1ee3p gi\u1eefa kh\u1ea3 n\u0103ng ti\u1ebfp c\u1eadn v\u00e0 linh ho\u1ea1t n\u00e0y khi\u1ebfn Pocket Option \u0111\u1eb7c bi\u1ec7t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n kh\u00e1m ph\u00e1 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u1ec1m n\u0103ng cao m\u00e0 kh\u00f4ng c\u1ea7n cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn ban \u0111\u1ea7u.<\/p>\n<h2>\ud83c\udf0d Celldex Therapeutics N\u0103m 2025: Nh\u00e0 \u0110\u1ed5i M\u1edbi Mi\u1ec5n D\u1ecbch H\u1ecdc<\/h2>\n<p>Celldex \u0111\u00e3 chuy\u1ec3n m\u00ecnh t\u1eeb c\u00f4ng ty t\u1eadp trung v\u00e0o ung th\u01b0 sang chuy\u00ean gia thu\u1ea7n t\u00fay v\u1ec1 mi\u1ec5n d\u1ecbch h\u1ecdc. Chi\u1ebfn l\u01b0\u1ee3c chuy\u1ec3n h\u01b0\u1edbng sang c\u00e1c b\u1ec7nh do t\u1ebf b\u00e0o mast trung gian th\u1ec3 hi\u1ec7n c\u00e1ch ti\u1ebfp c\u1eadn t\u1eadp trung \u0111\u1ec3 gi\u1ea3i quy\u1ebft c\u00e1c b\u1ec7nh vi\u00eam m\u00e3n t\u00ednh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi tr\u00ean to\u00e0n th\u1ebf gi\u1edbi.<\/p>\n<p>Thu\u1ed1c ch\u1ee7 l\u1ef1c c\u1ee7a c\u00f4ng ty, barzolvolimab, nh\u1eafm v\u00e0o th\u1ee5 th\u1ec3 KIT\u2014m\u1ed9t ph\u01b0\u01a1ng ph\u00e1p m\u1edbi c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh nh\u01b0 vi\u00eam m\u00e0y \u0111ay m\u00e3n t\u00ednh, prurigo nodularis v\u00e0 vi\u00eam th\u1ef1c qu\u1ea3n eosinophilic. V\u1edbi 186 nh\u00e2n vi\u00ean bao g\u1ed3m 87 nh\u00e0 khoa h\u1ecdc nghi\u00ean c\u1ee9u, h\u1ecd duy tr\u00ec n\u0103ng l\u1ef1c ph\u00e1t tri\u1ec3n n\u1ed9i b\u1ed9 m\u1ea1nh m\u1ebd (<a href=\"https:\/\/stockanalysis.com\/stocks\/cldx\/company\/\">H\u1ed3 S\u01a1 C\u00f4ng Ty<\/a>).<\/p>\n<p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb Cho N\u0103m 2025<\/strong>: Nh\u00f3m nghi\u00ean c\u1ee9u c\u1ee7a Celldex ph\u00e1t hi\u1ec7n r\u1eb1ng t\u1ebf b\u00e0o mast\u2014t\u1eebng \u0111\u01b0\u1ee3c coi l\u00e0 ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng \u0111\u01a1n gi\u1ea3n\u2014th\u1ef1c s\u1ef1 \u0111\u00f3ng vai tr\u00f2 trung t\u00e2m trong h\u01a1n 50 b\u1ec7nh vi\u00eam kh\u00e1c nhau, m\u1edf ra m\u1ed9t th\u1ecb tr\u01b0\u1eddng ti\u1ec1m n\u0103ng kh\u1ed5ng l\u1ed3 c\u00f3 th\u1ec3 v\u01b0\u1ee3t qu\u00e1 20 t\u1ef7 USD m\u1ed7i n\u0103m.<\/p>\n"},"faq":[{"question":"Celldex Therapeutics l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Celldex Therapeutics l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc chuy\u00ean v\u1ec1 c\u00e1c li\u1ec7u ph\u00e1p mi\u1ec5n d\u1ecbch h\u1ecdc, t\u1eadp trung v\u00e0o \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh vi\u00eam m\u00e3n t\u00ednh v\u00e0 c\u00e1c b\u1ec7nh li\u00ean quan \u0111\u1ebfn t\u1ebf b\u00e0o mast."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu CLDX?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu CLDX th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng m\u00f4i gi\u1edbi c\u00f3 truy c\u1eadp NASDAQ, th\u1ef1c hi\u1ec7n c\u00e1c b\u01b0\u1edbc x\u00e1c minh, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu CLDX, \u0111\u1eb7t l\u1ec7nh mua v\u1edbi gi\u00e1 gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a m\u00ecnh."},{"question":"R\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o Celldex Therapeutics l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, r\u00e0o c\u1ea3n ph\u00e1p l\u00fd t\u1eeb FDA, ti\u00eau hao ti\u1ec1n m\u1eb7t nhanh v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a c\u1ed5 phi\u1ebfu CLDX trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu CLDX c\u00f3 th\u1ec3 t\u0103ng l\u00ean 40-50 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 55-70 USD n\u0103m 2026, v\u00e0 l\u00ean \u0111\u1ebfn 150-200 USD v\u00e0o n\u0103m 2030 n\u1ebfu c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 ph\u00ea duy\u1ec7t th\u00e0nh c\u00f4ng."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o CLDX?","answer":"Pocket Option cung c\u1ea5p ti\u1ec1n g\u1eedi t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh ch\u00f3ng, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi mu\u1ed1n th\u1eed nghi\u1ec7m v\u1edbi c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng cao nh\u01b0 CLDX."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Celldex Therapeutics l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Celldex Therapeutics l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc chuy\u00ean v\u1ec1 c\u00e1c li\u1ec7u ph\u00e1p mi\u1ec5n d\u1ecbch h\u1ecdc, t\u1eadp trung v\u00e0o \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh vi\u00eam m\u00e3n t\u00ednh v\u00e0 c\u00e1c b\u1ec7nh li\u00ean quan \u0111\u1ebfn t\u1ebf b\u00e0o mast."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu CLDX?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu CLDX th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng m\u00f4i gi\u1edbi c\u00f3 truy c\u1eadp NASDAQ, th\u1ef1c hi\u1ec7n c\u00e1c b\u01b0\u1edbc x\u00e1c minh, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu CLDX, \u0111\u1eb7t l\u1ec7nh mua v\u1edbi gi\u00e1 gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a m\u00ecnh."},{"question":"R\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o Celldex Therapeutics l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, r\u00e0o c\u1ea3n ph\u00e1p l\u00fd t\u1eeb FDA, ti\u00eau hao ti\u1ec1n m\u1eb7t nhanh v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a c\u1ed5 phi\u1ebfu CLDX trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu CLDX c\u00f3 th\u1ec3 t\u0103ng l\u00ean 40-50 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 55-70 USD n\u0103m 2026, v\u00e0 l\u00ean \u0111\u1ebfn 150-200 USD v\u00e0o n\u0103m 2030 n\u1ebfu c\u00e1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 ph\u00ea duy\u1ec7t th\u00e0nh c\u00f4ng."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o CLDX?","answer":"Pocket Option cung c\u1ea5p ti\u1ec1n g\u1eedi t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh ch\u00f3ng, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi mu\u1ed1n th\u1eed nghi\u1ec7m v\u1edbi c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng cao nh\u01b0 CLDX."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T20:20:54+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX)\",\"datePublished\":\"2025-08-25T20:20:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-25T20:20:54+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T20:20:54+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX)","datePublished":"2025-08-25T20:20:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-25T20:20:54+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Celldex Therapeutics, Inc. (CLDX)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":351022,"slug":"how-to-buy-celldex-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Celldex Therapeutics, Inc. (CLDX) - Investimento em a\u00e7\u00f5es da Celldex Therapeutics, Inc. (CLDX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-celldex-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/351025","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=351025"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/351025\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=351025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=351025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=351025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}